Fangfang Bi
- Molecular Biology
- Cancer Research top 5%
- Oncology
- Reproductive Medicine top 5%
- Pulmonary and Respiratory Medicine
- Co-authors
- Qing YangDa LiTianshui SunZhuonan LiuYing ChenYuanyuan AnYiming ZhouJi-Min Cao
- Topics
- RNA modifications and cancer (12 papers)Cancer-related molecular mechanisms research (9 papers)Epigenetics and DNA Methylation (8 papers)
- Journals
- SHILAP Revista de lepidopterologíaScientific ReportsMolecular Cancer
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Fangfang Bi
47 papers receiving 963 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 560
- Cancer Research 347
- Oncology 194
- Reproductive Medicine 167
- Pulmonary and Respiratory Medicine 162
Countries citing papers authored by Fangfang Bi
This map shows the geographic impact of Fangfang Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Bi more than expected).
Fields of papers citing papers by Fangfang Bi
This network shows the impact of papers produced by Fangfang Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Bi. The network helps show where Fangfang Bi may publish in the future.
Co-authorship network of co-authors of Fangfang Bi
This figure shows the co-authorship network connecting the top 25 collaborators of Fangfang Bi. A scholar is included among the top collaborators of Fangfang Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfang Bi. Fangfang Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 12 | |
| 4 | 6 | |
| 5 | 8 | |
| 6 | 8 | |
| 7 | 36 | |
| 8 | 22 | |
| 9 | 2 | |
| 10 | Simvastatin Inhibits the Malignant Behaviors of Gastric Cancer Cells by Simultaneously Suppressing YAP and β-Catenin Signaling | 1 |
| 11 | 64 | |
| 12 | 9 | |
| 13 | 77 | |
| 14 | 15 | |
| 15 | 31 | |
| 16 | 24 | |
| 17 | 23 | |
| 18 | 19 | |
| 19 | 11 | |
| 20 | 8 |
About Fangfang Bi
Fangfang Bi is a scholar working on Reproductive Medicine, Cancer Research and Obstetrics and Gynecology, having authored 48 papers that have together received 984 indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (9 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Cancer Research (347 citations), Reproductive Medicine (167 citations) and Geriatrics and Gerontology (34 citations). Fangfang Bi has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Qing Yang, Da Li, Tianshui Sun, Zhuonan Liu, Qing Yang, Ying Chen, Yuanyuan An, Yiming Zhou, Ji-Min Cao and Ying Chen. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.